$1.56 Billion is the total value of Avidity Partners Management LP's 57 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 119.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | Buy | ABBVIE INC | $151,727,000 | +317.5% | 1,545,400 | +224.0% | 9.72% | +93.6% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $82,384,000 | +237.4% | 132,100 | +164.2% | 5.28% | +56.5% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $80,750,000 | +339.4% | 1,104,500 | +104.5% | 5.18% | +103.8% |
| BAX | New | BAXTER INTL INC | $68,957,000 | – | 800,900 | +100.0% | 4.42% | – |
| IMMU | Buy | IMMUNOMEDICS INC | $67,736,000 | +919.2% | 1,911,300 | +287.7% | 4.34% | +373.0% |
| EXEL | Buy | EXELIXIS INC | $63,957,000 | +242.0% | 2,694,070 | +148.1% | 4.10% | +58.6% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $56,984,000 | +296.7% | 507,700 | +217.3% | 3.65% | +84.0% |
| HOLX | New | HOLOGIC INC | $46,580,000 | – | 817,200 | +100.0% | 2.99% | – |
| SGEN | Sell | SEATTLE GENETICS INC | $42,633,000 | -36.3% | 250,900 | -56.7% | 2.73% | -70.4% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $40,212,000 | +134.5% | 2,474,599 | +109.4% | 2.58% | +8.7% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $38,261,000 | +80.3% | 1,150,000 | +47.4% | 2.45% | -16.4% |
| CCXI | Buy | CHEMOCENTRYX INC | $37,159,000 | +291.9% | 645,800 | +173.6% | 2.38% | +81.8% |
| ARVN | New | ARVINAS INC | $36,119,000 | – | 1,076,900 | +100.0% | 2.32% | – |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $33,315,000 | +187.4% | 404,900 | +105.5% | 2.14% | +33.3% |
| KDMN | Buy | KADMON HLDGS INC | $32,905,000 | +177.7% | 6,426,700 | +127.3% | 2.11% | +28.8% |
| PRNB | New | PRINCIPIA BIOPHARMA INC | $32,795,000 | – | 548,500 | +100.0% | 2.10% | – |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $32,389,000 | – | 674,487 | +100.0% | 2.08% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $29,802,000 | +202.2% | 536,200 | +61.0% | 1.91% | +40.1% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $28,718,000 | +344.3% | 559,700 | +173.0% | 1.84% | +106.2% |
| AVTR | New | AVANTOR INC | $27,404,000 | – | 1,612,000 | +100.0% | 1.76% | – |
| VIR | New | VIR BIOTECHNOLOGY INC | $25,426,000 | – | 620,600 | +100.0% | 1.63% | – |
| MRSN | New | MERSANA THERAPEUTICS INC | $25,029,000 | – | 1,069,600 | +100.0% | 1.60% | – |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $23,720,000 | +75.7% | 2,674,154 | -30.1% | 1.52% | -18.5% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $22,636,000 | – | 1,527,400 | +100.0% | 1.45% | – |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $22,582,000 | +166.2% | 185,100 | +88.9% | 1.45% | +23.5% |
| SYNH | New | SYNEOS HEALTH INCcl a | $21,349,000 | – | 366,500 | +100.0% | 1.37% | – |
| BMYRT | New | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $20,717,000 | – | 5,786,941 | +100.0% | 1.33% | – |
| BTAI | Buy | BIOXCEL THERAPEUTICS INC | $20,573,000 | +336.2% | 388,095 | +83.9% | 1.32% | +102.3% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $20,273,000 | – | 738,547 | +100.0% | 1.30% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $20,158,000 | – | 274,300 | +100.0% | 1.29% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $20,025,000 | – | 1,206,351 | +100.0% | 1.28% | – |
| MCK | Sell | MCKESSON CORP | $19,638,000 | -40.3% | 128,000 | -47.3% | 1.26% | -72.3% |
| IDYA | New | IDEAYA BIOSCIENCES INC | $18,915,000 | – | 1,331,100 | +100.0% | 1.21% | – |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $18,280,000 | +195.0% | 1,023,500 | +167.9% | 1.17% | +36.9% |
| EDIT | New | EDITAS MEDICINE INC | $17,748,000 | – | 600,000 | +100.0% | 1.14% | – |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $17,585,000 | +160.2% | 118,900 | +98.2% | 1.13% | +20.7% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $17,242,000 | – | 325,990 | +100.0% | 1.10% | – |
| ALEC | Sell | ALECTOR INC | $16,776,000 | -2.6% | 686,400 | -3.9% | 1.08% | -54.9% |
| MDT | New | MEDTRONIC PLC | $15,928,000 | – | 173,700 | +100.0% | 1.02% | – |
| PRVL | New | PREVAIL THERAPEUTICS INC | $15,329,000 | – | 1,028,800 | +100.0% | 0.98% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $14,572,000 | – | 589,000 | +100.0% | 0.93% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $14,394,000 | – | 1,438,000 | +100.0% | 0.92% | – |
| ANIK | Buy | ANIKA THERAPEUTICS INC | $13,677,000 | +181.6% | 362,490 | +115.8% | 0.88% | +30.7% |
| SURF | New | SURFACE ONCOLOGY INC | $9,700,000 | – | 1,478,699 | +100.0% | 0.62% | – |
| RPRX | New | ROYALTY PHARMA PLC | $9,710,000 | – | 200,000 | +100.0% | 0.62% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $9,332,000 | – | 156,266 | +100.0% | 0.60% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $8,790,000 | – | 418,178 | +100.0% | 0.56% | – |
| VSTM | Buy | VERASTEM INC | $7,594,000 | +3.1% | 4,414,991 | +58.2% | 0.49% | -52.2% |
| ONEM | New | 1LIFE HEALTHCARE INC | $7,264,000 | – | 200,000 | +100.0% | 0.47% | – |
| AKUS | New | AKOUOS INC | $7,088,000 | – | 315,000 | +100.0% | 0.45% | – |
| RNA | New | AVIDITY BIOSCIENCES INC | $6,636,000 | – | 234,814 | +100.0% | 0.42% | – |
| RTRX | New | RETROPHIN INC | $5,103,000 | – | 250,000 | +100.0% | 0.33% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $4,256,000 | – | 100,000 | +100.0% | 0.27% | – |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $3,700,000 | +22.0% | 457,951 | +19.9% | 0.24% | -43.4% |
| FUSN | New | FUSION PHARMACEUTICALS INC | $2,875,000 | – | 164,554 | +100.0% | 0.18% | – |
| ZGNX | New | ZOGENIX INC | $2,643,000 | – | 97,870 | +100.0% | 0.17% | – |
| PROG | New | PROGENITY INC | $2,148,000 | – | 238,680 | +100.0% | 0.14% | – |
| Exit | -- | $0 | – | 0 | +100.0% | 0.00% | – | |
| COLL | Exit | COLLEGIUM PHARMACEUTICAL INC | $0 | – | -17,000 | -100.0% | -0.04% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -4,310,000 | -100.0% | -0.25% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -444,200 | -100.0% | -0.37% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -408,000 | -100.0% | -0.81% | – |
| NERV | Exit | MINERVA NEUROSCIENCES INCcall | $0 | – | -990,000 | -100.0% | -0.82% | – |
| AMRN | Exit | AMARIN CORP PLCcall | $0 | – | -1,624,800 | -100.0% | -0.90% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -507,000 | -100.0% | -0.95% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -40,000 | -100.0% | -0.98% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -57,000 | -100.0% | -0.99% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -735,000 | -100.0% | -1.02% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -102,000 | -100.0% | -1.02% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -80,000 | -100.0% | -1.08% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -34,000 | -100.0% | -1.12% | – |
| HUM | Exit | HUMANA INC | $0 | – | -33,000 | -100.0% | -1.43% | – |
| MRNA | Exit | MODERNA INC | $0 | – | -365,000 | -100.0% | -1.51% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -237,000 | -100.0% | -1.55% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -65,000 | -100.0% | -1.59% | – |
| SGEN | Exit | SEATTLE GENETICS INCcall | $0 | – | -117,700 | -100.0% | -1.88% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -166,000 | -100.0% | -2.06% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -200,000 | -100.0% | -2.07% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -357,000 | -100.0% | -2.08% | – |
| CVS | Exit | CVS HEALTH CORP | $0 | – | -277,000 | -100.0% | -2.27% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -62,000 | -100.0% | -2.71% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -411,000 | -100.0% | -2.95% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -295,000 | -100.0% | -3.13% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -505,000 | -100.0% | -3.35% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -302,000 | -100.0% | -3.53% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -492,000 | -100.0% | -5.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.